Elizabeth Trehu, Chief Medical Officer at Jounce Therapeutics, Inc. (JNCE), sold 8,383 shares at $7.30 ($58K) on 2022-01-07, disclosed to the SEC on 2022-01-11.
Open-market sale of $58k JNCE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.30 | 3,005 | $22K | 38.0% |
| 2 | $6.65 | 5,378 | $36K | 62.0% |
| Total | $6.88 avg | 8,383 | $58K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-22 | $78K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $36K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |